Consort Medical (OTCMKTS:CSRMY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, January 9th.
According to Zacks, “Consort Medical Plc engages in the design, development, manufacture and sale of medical drug delivery devices. It operates through the Bespak and Aesica segments. Bespak segment develops and produces drug delivery devices which serves pharmaceutical companies with inhaler and auto-injector technologies. Aesica segment is a contract development and manufacturing organization which serves pharmaceutical firms with active pharmaceutical ingredient and finished dose formulation development and manufacturing services. Consort Medical Plc is headquartered in Hemel Hempstead, United Kingdom. “
Shares of Consort Medical (OTCMKTS:CSRMY) remained flat at $$16.65 during trading on Tuesday. Consort Medical has a twelve month low of $13.00 and a twelve month high of $16.65.
TRADEMARK VIOLATION WARNING: “Consort Medical (OTCMKTS:CSRMY) Downgraded to Hold at Zacks Investment Research” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/04/consort-medical-csrmy-cut-to-hold-at-zacks-investment-research.html.
Consort Medical Company Profile
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
Get a free copy of the Zacks research report on Consort Medical (CSRMY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.